arrow
B

Bettina Wedi

Hannover Medical School
H指数:45
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation

KIT D816V在过敏性休克或系统性肥大细胞活化中的流行率

2025-10-250
OAAI
Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema

与ACE抑制剂和血管紧张素受体阻滞剂诱导的血管性水肿相关的非遗传因素

2025-05-070
OA
S3 guideline: Diagnosis and treatment of epidermal necrolysis(Stevens-Johnson syndrome and toxic epidermal necrolysis) -Part 2: Supportive therapy of EN in the acute and post-acute stages

S3指南: 表皮坏死松解症 (stevens-johnson综合征和中毒性表皮坏死松解症) 的诊断和治疗.第2部分: 急性和急性后阶段EN的支持治疗

2024-11-070
OAAI
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages
2024-10-170
OAAI
S3-Leitlinie: Diagnostik und Therapie der epidermalen Nekrolyse (Stevens-Johnson-Syndrom und toxisch epidermale Nekrolyse) - Teil 1: Diagnostik, initiales Management und immunmodulierende Systemtherapie

S3指南:表皮坏死(Stevens-Johnson综合征和中毒性表皮坏死)的诊断与治疗——第1部分:诊断、初始管理和免疫调节系统性治疗

2024-10-110
OAAI
Obituary: Professor Marcus Maurer, Berlin, Germany
2024-09-280
PRE
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy
2024-09-230
OAAI
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus
2024-04-012
OA
Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics

致命性和近致命性过敏反应: 来自欧洲过敏反应登记和国家卫生统计的数据

2024-01-0111
PRE
S3 Guideline Urticaria. Part 2: Treatment of urticaria - German-language adaptation of the international S3 guideline
2023-02-023
OAAI
S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline
2023-01-314
OAAI